Orbit Discovery

Orbit Discovery

Private
Oxford, EnglandHealthcare & Life Scienceshttps://www.orbitdiscovery.com

Last Round

Grant

Jun 13, 2022

Total Funding Raised

$9.21M

Company Overview

Orbit Discovery is a biopharmaceutical company that spun out of the University of Oxford in 2015, specializing in peptide drug discovery. It provides therapeutic discovery services to the biotechnology and pharmaceutical industries using its proprietary platform, which integrates a bead-based peptide display engine with microfluidic technologies. This technology enables high-throughput affinity and functional screening of large peptide libraries to identify candidates for various applications, including radiopharmaceuticals, nucleic acid delivery, and targeting G-protein coupled receptors (GPCRs). The company is privately held, backed by venture capital, and actively engages in collaborations with industry partners to discover and develop novel peptide therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

peptide drug discoverydrug discovery platformcontract research organizationCROfunctional screeninghigh-throughput screeningHTSpeptide librariesbead-based displayaffinity screeningmicrofluidics platformGPCR drug discoveryDNA-encoded librariesDELdrug discovery enginebiopharmauniversity spin-out

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orbit Discovery Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Orbit Discovery Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJun 13, 2022
VC RoundJul 20, 2021
Series AMay 23, 2018
SeedJan 26, 2016

Key People

Founding team and executive leadership

Neil Butt

Chief Executive Officer

Executive Team

Orbit Discovery Investors

Notable investors and investment history

InvestorRounds
Oxford Science EnterprisesSeed, Series A, VC Round
Perivoli InnovationsSeries A, VC Round
Innovate UKGrant
Borealis VenturesSeries A, VC Round

Orbit Discovery Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orbit Discovery Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orbit Discovery's valuation, stock price, and market status.

Firmographic Details

HeadquartersOxford, England
Employee Range28
Year Founded2015
Last FundingJun 13, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.